Fortune 500 Pharmaceutical Company Legacy Real Estate Asset Closure and Divestiture Strategy (client confidential)
Financial restructure and divestiture analysis of a large tract R&D facility
Asset and liability assessment, quantification, monetization, and mitigation analysis, including environmental remediation and demolition liability
Market feasibility study, highest and best use analysis and development of a TOD-oriented master plan for mixed use residential, retail, and office use/reuse.
The RESIGHT Solution
Identification and financial analysis of a range of divestiture/reuse options including like-kind sale, “as is, where is” sale, mixed use residential/commercial sale/leaseback and long-term custodial care